Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy

References

• D’Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Bio. 2007;8(10):813–824. doi:10.1038/nrm225617848967
   PubMed Web of Science ®Google Scholar
• Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins - Vitamin-E and Vitamin-C, beta-carotene, and other carotenoids. Ann Ny Acad Sci. 1992;669:7–20. doi:10.1111/j.1749-6632.1992.tb17085.x1444060
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress - from basic research to clinical-application. Am J Med. 1991;91:S31–S38. doi:10.1016/0002-9343(91)90281-2
   PubMed Web of Science ®Google Scholar
• Minelli A, Bellezza I, Conte C, Culig Z. Oxidative stress-related aging: a role for prostate cancer? Biochim Biophys Acta. 2009;1795(2):83–91.19121370
   PubMed Web of Science ®Google Scholar
• Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Bio. 2007;8(9):722a–728a.17700625
   PubMed Web of Science ®Google Scholar
• Di Virgilio F. New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. Curr Pharm Design. 2004;10(14):1647–1652. doi:10.2174/1381612043384727
   PubMed Web of Science ®Google Scholar
• Dugan LL, Quick KL. Reactive oxygen species and aging: evolving questions. Sci Aging Knowledge Environ. 2005;2005(26):pe20. doi:10.1126/sageke.2005.26.pe2015994214
   PubMedGoogle Scholar
• Muhammad S, Bierhaus A, Schwaninger M. Reactive oxygen species in diabetes-induced vascular damage, stroke, and alzheimer’s disease. J Alzheimers Dis. 2009;16(4):775–785. doi:10.3233/JAD-2009-098219387112
   PubMedGoogle Scholar
• Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res. 2004;37(8):1263–1273. doi:10.1590/S0100-879X200400080001815273829
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761. doi:10.1172/JCI2162515599400
   PubMed Web of Science ®Google Scholar
• Johar R, Sharma R, Kaur A, Mukherjee TK. Role of reactive oxygen species in estrogen dependant breast cancer complication. Anti-Cancer Agent Me. 2016;16(2):190–199. doi:10.2174/1871520615666150518092315
   Web of Science ®Google Scholar
• Sharma A, Rajappa M, Satyam A, Sharma M. Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response. Mol Cell Biochem. 2010;341(1–2):65–72. doi:10.1007/s11010-010-0437-220354762
   PubMedGoogle Scholar
• Chan DW, Liu VWS, Tsao GSW, et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis. 2008;29(9):1742–1750. doi:10.1093/carcin/bgn16718632752
   PubMedGoogle Scholar
• Edderkaoui M, Hong P, Vaquero EC, et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am J Physiol Gastrointest Liver Physiol. 2005;289(6):G1137–1147. doi:10.1152/ajpgi.00508.200416037546
   PubMed Web of Science ®Google Scholar
• Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 2008;11(1):1–15. doi:10.1080/1093740070143646018176884
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Z, Ye Y, Xie L, Li W. Oxidative stress and liver cancer: etiology and therapeutic targets. Oxid Med Cell Longev. 2016;2016:7891574. doi:10.1155/2016/789157427957239
   PubMedGoogle Scholar
• Bur H, Haapasaari K-M, Turpeenniemi-Hujanen T, et al. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas. Histopathology. 2014;65(3):319–327. doi:10.1111/his.1238924698430
   PubMedGoogle Scholar
• Salganik RI, Albright CD, Rodgers J, et al. Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis. 2000;21(5):909–914. doi:10.1093/carcin/21.4.70110783311
   PubMedGoogle Scholar
• Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106(Suppl 1):289–295.9539021
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615–627. doi:10.1038/nrd259120616808
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760. doi:10.1038/nnano.2007.38718654426
   PubMed Web of Science ®Google Scholar
• Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev. 2013;65(1):21–23. doi:10.1016/j.addr.2012.04.01022580334
   PubMed Web of Science ®Google Scholar
• Skotland T, Iversen TG, Sandvig K. Development of nanoparticles for clinical use. Nanomedicine (Lond). 2014;9(9):1295–1299. doi:10.2217/nnm.14.8125204821
   PubMed Web of Science ®Google Scholar
• Pu HL, Chiang WL, Maiti B, et al. Nanoparticles with dual responses to oxidative stress and reduced ph for drug release and anti-inflammatory applications. ACS Nano. 2014;8(2):1213–1221. doi:10.1021/nn405878724386907
   PubMedGoogle Scholar
• Dickinson BC, Chang CJ. A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc. 2008;130(30):9638–9639. doi:10.1021/ja802355u18605728
   PubMed Web of Science ®Google Scholar
• Savina A, Peres A, Cebrian I, et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity. 2009;30(4):544–555. doi:10.1016/j.immuni.2009.01.01319328020
   PubMed Web of Science ®Google Scholar
• de Gracia Lux C, Joshi-Barr S, Nguyen T, et al. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J Am Chem Soc. 2012;134(38):15758–15764. doi:10.1021/ja303372u22946840
   PubMedGoogle Scholar
• Shim MS, Xia Y. A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells. Angew Chem Int Ed Engl. 2013;52(27):6926–6929. doi:10.1002/anie.20120963323716349
   PubMed Web of Science ®Google Scholar
• Jager E, Hocherl A, Janouskova O, et al. Fluorescent boronate-based polymer nanoparticles with reactive oxygen species (ROS)-triggered cargo release for drug-delivery applications. Nanoscale. 2016;8(13):6958–6963. doi:10.1039/C6NR00791K26961769
   PubMedGoogle Scholar
• Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479–496. doi:10.3109/1071576100366755420370557
   PubMed Web of Science ®Google Scholar
• Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat Rev Immunol. 2013;13(5):349–361. doi:10.1038/nri342323618831
   PubMed Web of Science ®Google Scholar
• Guillen J. FELASA guidelines and recommendations. J Am Assoc Lab Anim Sci. 2012;51(3):311–321.22776188
   PubMed Web of Science ®Google Scholar
• Knapp W, Dorken B, Rieber P, Schmidt RE, Stein H, von dem Borne AE. CD antigens 1989. Int J Cancer. 1989;44(1):190–191. doi:10.1002/ijc.29104401352744892
   PubMedGoogle Scholar
• Khazen W, M’Bika JP, Tomkiewicz C, et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett. 2005;579(25):5631–5634. doi:10.1016/j.febslet.2005.09.03216213494
   PubMed Web of Science ®Google Scholar
• Komohara Y, Fujiwara Y, Ohnishi K, Takeya M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev. 2016;99(Pt B):180–185. doi:10.1016/j.addr.2015.11.00926621196
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Y, Wang Y, Fan M, Luo F, Qian Z. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int J Pharm. 2011;414(1–2):251–259. doi:10.1016/j.ijpharm.2011.05.01421596124
   PubMed Web of Science ®Google Scholar
• Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881–1896.15769673
   PubMed Web of Science ®Google Scholar
• Huang D, Zhuang Y, Shen H, Yang F, Wang X, Wu D. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery. Mater Sci Eng C Mater Biol Appl. 2018;82:60–68. doi:10.1016/j.msec.2017.08.06329025675
   PubMed Web of Science ®Google Scholar
• Lu J, Chuan X, Zhang H, et al. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Int J Pharm. 2014;471(1–2):525–535. doi:10.1016/j.ijpharm.2014.05.03224858391
   PubMedGoogle Scholar
• Jager E, Giacomelli FC. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches. Curr Top Med Chem. 2015;15(4):328–344. doi:10.2174/156802661566615013015230025633209
   PubMedGoogle Scholar
• Bargagli E, Olivieri C, Bennett D, Prasse A, Muller-Quernheim J, Rottoli P. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med. 2009;103(9):1245–1256. doi:10.1016/j.rmed.2009.04.01419464864
   PubMed Web of Science ®Google Scholar
• Corzo CA, Cotter MJ, Cheng P, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol. 2009;182(9):5693–5701. doi:10.4049/jimmunol.080277519380816
   PubMed Web of Science ®Google Scholar
• Barja G. Mitochondrial oxygen consumption and reactive oxygen species production are independently modulated: implications for aging studies. Rejuvenation Res. 2007;10(2):215–224. doi:10.1089/rej.2006.051617523876
   PubMed Web of Science ®Google Scholar
• Logan A, Shabalina IG, Prime TA, et al. In vivo levels of mitochondrial hydrogen peroxide increase with age in mtDNA mutator mice. Aging Cell. 2014;13(4):765–768. doi:10.1111/acel.1225524621297
   PubMedGoogle Scholar
• Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78(2):547–581. doi:10.1152/physrev.1998.78.2.5479562038
   PubMed Web of Science ®Google Scholar
• Brand MD. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol. 2000;35(6–7):811–820. doi:10.1016/S0531-5565(00)00135-211053672
   PubMed Web of Science ®Google Scholar
• Pavelescu LA. On reactive oxygen species measurement in living systems. J Med Life. 2015;8(Spec Issue):38–42.
   PubMedGoogle Scholar
• Larsen SK, Gao Y, Basse PH. NK cells in the tumor microenvironment. Crit Rev Oncog. 2014;19(1–2):91–105. doi:10.1615/CritRevOncog.v19.i1-224941376
   PubMedGoogle Scholar
• Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi:10.1016/j.cell.2010.03.01420371344
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005;23(4):344–346. doi:10.1016/j.immuni.2005.10.00116226499
   PubMed Web of Science ®Google Scholar
• Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 2014;105(1):1–8. doi:10.1111/cas.1231424168081
   PubMed Web of Science ®Google Scholar
• Brown ER, Charles KA, Hoare SA, et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol. 2008;19(7):1340–1346. doi:10.1093/annonc/mdn05418325912
   PubMedGoogle Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.02520303878
   PubMed Web of Science ®Google Scholar
• Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605–612. doi:10.1158/0008-5472.CAN-05-400516423985
   PubMed Web of Science ®Google Scholar
• Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin Cancer Res. 2010;16(18):4583–4594. doi:10.1158/1078-0432.CCR-10-061320702612
   PubMed Web of Science ®Google Scholar
• Fusser M, Overbye A, Pandya AD, et al. Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. J Control Release. 2018;293:183–192. doi:10.1016/j.jconrel.2018.11.02730529259
   PubMedGoogle Scholar
• Wanderley CW, Colon DF, Luiz JPM, et al. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Res. 2018. doi:10.1158/0008-5472.CAN-17-3480
   PubMed Web of Science ®Google Scholar